In the latest edition of Medical Plastics News, group editor Lu Rahman discusses issues of data security and whether we should trust connected medical devices. more

13 Nov 2017 15:45 Opinion

Healthcare company Abbott has announced that its FreeStyle Libre sensor is now available on prescription in England, Wales, Northern Ireland & Scotland. more

1 Nov 2017 12:05 Devices

In a move that’s sure to please adults with diabetes in the US, the FDA has approved a glucose monitoring device that doesn’t require the user to prick themselves for a blood sample. more

29 Sep 2017 10:40 Devices

A number of medical manufacturers based in Puerto Rico have responded to the impact and damage caused by hurricane Maria. more

25 Sep 2017 14:50 News

A system designed to automatically measure glucose levels through a sensor has been approved by the NHS and will be available for reimbursement across England, Wales, Scotland and Northern Ireland from 1 November. more

13 Sep 2017 15:40 News

Medical Plastics News takes a look at some of the biggest stories that have emerged over the past week. more

4 Sep 2017 16:05 News

Over 500,000 pacemakers developed by medical device maker Abbott have been shown to contain cyber-security issues. more

31 Aug 2017 10:25 Devices

Healthcare company Abbott has announced that its smartphone compatible Confirm Insertable Cardiac Monitor (ICM) has gained CE Mark approval. more

9 May 2017 11:45 Devices

The Food and Drug Administration (FDA) has warned medical device maker Abbott that it must submit a plan to address any cybersecurity issues and other safety issues identified in cardiac devices from the company’s recently acquired St Jude Medical. more

21 Apr 2017 10:00 News

Abbott is aiming to recruit more than 150 people to work at its UK diabetes care manufacturing hub in Witney, Oxfordshire more

6 May 2016 15:58 News

The US Food and Drug Administration (FDA) Advisory Committee gives Abbott’s fully dissolving heart stent a positive review and recommends the FDA approve it more

17 Mar 2016 10:46 News

A drug-eluting coronary stent made of a biodegradable polymer performed similarly to the gold-standard metal one in a non-inferiority trial among patients with the more serious type of heart attack known as ST-segment elevation myocardial infarction more

19 Nov 2015 17:00 News

Abbott has announced positive one-year clinical results from the Absorb III trial more

19 Oct 2015 14:49 News

Diabetes Professional Care 2015 will take place at the Barbican Exhibition Centre in London from 11-12 November more

7 Oct 2015 10:05 News

Done deal: Abbott has completed its acquisition of Topera, a medical device company focused on developing innovative electrophysiology technologies more

23 Dec 2014 10:39 News

In the lead: The growing market for glucose monitoring devices in Benelux and Scandinavian countries is currently led by Roche more

6 Jul 2014 17:33 News

Enlight from St Jude Medical.

Source: St Jude Medical.

Technologies for minimally invasive devices are a fast developing area. As tubes get smaller, thinner and stronger, surgeons are expected to be able to access areas of the body with more accuracy and less pain for the patient. more

22 Jul 2013 08:00 Devices

BASF's announcement of a €10 bn investment over seven years in Asia will stimulate much activity in the region, especially in plastics. Clinical trials of Abbott's Absorb stent in Japan are influential too. more

2 Jul 2013 00:00 News

Abbott (NYSE: ABT) today announced CE Marking (Conformité Européenne) for the ARCHITECT clinical chemistry Hemoglobin A1c (HbA1c) test, which may aid physicians in diagnosing and monitoring diabetes as well as identifying patients at risk for develop more

9 May 2013 00:00 News

US headquartered healthcare product manufacturer Abbott has published data which the company says supports the long-term performance of its Absorb bioresorbable vascular stent. more

15 Mar 2013 00:00 Devices